The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase

42Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Anaplastic lymphoma kinase (ALK) plays an important causative role in some cancers. Results: Novel views of the ALK activation loop are provided by several new crystal structures. Conclusion: Certain neuroblastoma mutations and inhibitors stabilize alternative, inactive ALK conformations. Significance: Novel kinase conformations may aid the design of a new generation of selective ALK inhibitors. © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Epstein, L. F., Chen, H., Emkey, R., & Whittington, D. A. (2012). The R1275Q neuroblastoma mutant and certain ATP-competitive inhibitors stabilize alternative activation loop conformations of anaplastic lymphoma kinase. Journal of Biological Chemistry, 287(44), 37447–37457. https://doi.org/10.1074/jbc.M112.391425

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free